Genetic Testing Market Analysis

Disease (Cancer, Alzheimer’s, Thalassemia, Cystic Fibrosis, Huntington Disease, Duchene Muscular Dystrophy)

The cancer segment is estimated to hold 25% share of the global genetic testing market in the coming years owing to the growing prevalence of cancers owing to genetic inherent. However, parents can't pass on cancer to their offspring. Furthermore, tumor cells' altered genetic makeup cannot be passed on to offspring. 

Yet, if a cancer-risk-raising genetic mutation exists in a parent's sperm or egg cells, it could be inherited (transmitted). Hence, owing to this factor the genetic testing demand is growing. If a person has inherited a genetic alteration that raises the risk of developing cancer, several genetic testing could reveal this. Normally, a little amount of blood is used for the cancer screening, but it is also occasionally possible to use saliva, cells from inside the cheek, or skin cells.

As per the estimates, inherited genetic alterations could account for up to 10% of cancer cases.

Test Type (Carrier Testing, Predictive Testing, Diagnostic Testing, Parental & Newborn Testing, Nutrigenomics, Pharmacogenomics)

Genetic testing market from the diagnostic testing segment is set to garner a notable share shortly backed by growing cases of chronic disease that need to be diagnosed. Long-lasting disorders known as chronic diseases could typically be managed but not cured. Individuals who have chronic conditions sometimes struggle with managing day-to-day symptoms that impair their quality of life, as well as acute health issues and consequences that may reduce their life expectancy.

In addition, chronic diseases including depression and back pain are frequently the main causes of decreased productivity and rising healthcare expenses. However, chronic diseases and their repercussions could frequently be avoided or effectively managed by effective behavior change initiatives, adequate medical therapy, and thorough monitoring to identify new issues. Hence, the need for diagnostic tests is growing, further boosting the market growth. According to estimates, globally, more than 40 million people die from chronic diseases each year.

Our in-depth analysis of the global market includes the following segments: